September 30, 2026

How do multifood allergy treatments compare?

Investigators compared omalizumab with omalizumab-facilitated multiallergen oral immunotherapy.

MDSpire News

August 07, 2026

FDA Approves Viral Therapy Plus Nivolumab

Accelerated approval is based on objective response rate and duration of response in advanced melanoma, with postapproval trials required to confirm clinical benefit.

MDSpire News